Tumor-suppressive Activity of Retinoic Acid Receptor-beta in Cancer

Overview

Journal Cancer Lett

Specialty Oncology

Date 2006 Dec 26

PMID 17188427

Citations 52

Authors

Xiao-chun Xu

Affiliations

Soon will be listed here.

Abstract

Retinoids, a group of structural and functional analogs of vitamin A, are known to regulate a large number of essential biological processes and to suppress carcinogenesis. The effects of retinoids are mainly mediated by nuclear retinoid receptors, which include retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Each receptor has three subtypes (alpha, beta, and gamma) and each subtype has different isoforms. Retinoic acid receptor-beta (RAR-beta) has four isoforms that have different affinities to retinoids and different biological functions. Loss of expression of RAR-beta(2) during cancer development is associated with tumorigenesis and retinoid resistance; induction of its expression, on the other hand, can suppress carcinogenesis. Expression of another isoform, RAR-beta(4), is increased in various types of cancer. RAR-beta(4) transgenic mice develop hyperplasia and neoplasia in various tissues, and induction of RAR-beta(4) expression increases the growth of tumor cells that do not express RAR-beta(2). Future studies will focus on molecular pathways involving RAR-beta(2) and the role of RAR-beta(4) in cancer development.

Citing Articles

Retinoic acid receptor-β deletion in a model of early pancreatic ductal adenocarcinoma (PDAC) tumorigenesis.

Mere Del Aguila E, Tang X, Gudas L Am J Cancer Res. 2025; 15(1):127-140.

PMID: 39949931 PMC: 11815370. DOI: 10.62347/XFOT8509.

RARB associated with MSI, affects progression and prognosis of gastric cancer.

Cai X, Lin W, Wu F, Song G, Qian Z, Wang Y BMC Gastroenterol. 2024; 24(1):285.

PMID: 39179979 PMC: 11342619. DOI: 10.1186/s12876-024-03339-z.

Exploring the nexus of nuclear receptors in hematological malignancies.

Manickasamy M, Sajeev A, BharathwajChetty B, AlQahtani M, Abbas M, Hegde M Cell Mol Life Sci. 2024; 81(1):78.

PMID: 38334807 PMC: 10858172. DOI: 10.1007/s00018-023-05085-z.

Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.

Mesgari H, Esmaelian S, Nasiri K, Ghasemzadeh S, Doroudgar P, Payandeh Z Cancers (Basel). 2023; 15(23).

PMID: 38067304 PMC: 10705512. DOI: 10.3390/cancers15235600.

Genetic analysis of potential biomarkers and therapeutic targets in neuroinflammation from sporadic Creutzfeldt-Jakob disease.

Cheng Y, Chen T, Hu J Sci Rep. 2023; 13(1):14122.

PMID: 37644077 PMC: 10465546. DOI: 10.1038/s41598-023-41066-9.

References

Lippman S, BATSAKIS J, Toth B, Weber R, Lee J, Martin J . Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med. 1993; 328(1):15-20. DOI: 10.1056/NEJM199301073280103. View

Houle B, Rochette-Egly C, BRADLEY W . Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci U S A. 1993; 90(3):985-9. PMC: 45795. DOI: 10.1073/pnas.90.3.985. View

van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H . EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst. 2000; 92(12):977-86. DOI: 10.1093/jnci/92.12.977. View

Huang J, Liang Z, Wu T, Hoque A, Chen H, Jiang Y . Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer. Cancer Res. 2007; 67(4):1589-93. DOI: 10.1158/0008-5472.CAN-06-2472. View

MOON T, Levine N, Cartmel B, Bangert J, Rodney S, Dong Q . Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997; 6(11):949-56. View

Grote H, Schmiemann V, Geddert H, Rohr U, Kappes R, Gabbert H . Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer. 2005; 116(5):720-5. DOI: 10.1002/ijc.21090. View

Hong W, Lippman S, Itri L, Karp D, Lee J, Byers R . Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990; 323(12):795-801. DOI: 10.1056/NEJM199009203231205. View

Meyskens Jr F, Surwit E, MOON T, Childers J, Davis J, Dorr R . Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst. 1994; 86(7):539-43. DOI: 10.1093/jnci/86.7.539. View

Berard J, Laboune F, Mukuna M, Masse S, Kothary R, BRADLEY W . Lung tumors in mice expressing an antisense RARbeta2 transgene. FASEB J. 1996; 10(9):1091-7. DOI: 10.1096/fasebj.10.9.8801172. View

10.

McGregor F, Muntoni A, Fleming J, Brown J, Felix D, MacDonald D . Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res. 2002; 62(16):4757-66. View

11.

Xu X, Stier U, Rosewicz S, ElNaggar A, Lotan R . Selective suppression of nuclear retinoic acid receptor beta gene expression in human pancreatic carcinomas. Int J Oncol. 2011; 8(3):445-51. DOI: 10.3892/ijo.8.3.445. View

12.

Hu L, Crowe D, Rheinwald J, Chambon P, Gudas L . Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991; 51(15):3972-81. View

13.

Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K . Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res. 2005; 11(3):1219-25. View

14.

Fang M, Wang Y, Ai N, Hou Z, Sun Y, Lu H . Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003; 63(22):7563-70. View

15.

Peng X, Maruo T, Cao Y, Punj V, Mehta R, Das Gupta T . A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells. Cancer Res. 2004; 64(24):8911-8. DOI: 10.1158/0008-5472.CAN-04-1810. View

16.

Xu X, Clifford J, Hong W, Lotan R . Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry. Diagn Mol Pathol. 1994; 3(2):122-31. DOI: 10.1097/00019606-199406000-00009. View

17.

Houle B, Pelletier M, Wu J, Goodyer C, BRADLEY W . Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines. Cancer Res. 1994; 54(2):365-9. View

18.

Delage B, Bairras C, Buaud B, Pallet V, Cassand P . A high-fat diet generates alterations in nuclear receptor expression: prevention by vitamin A and links with cyclooxygenase-2 and beta-catenin. Int J Cancer. 2005; 116(6):839-46. DOI: 10.1002/ijc.21108. View

19.

Sirchia S, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R . Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res. 2002; 62(9):2455-61. View

20.

Sommer K, Chen L, Treuting P, Smith L, Swisshelm K . Elevated retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc Natl Acad Sci U S A. 1999; 96(15):8651-6. PMC: 17571. DOI: 10.1073/pnas.96.15.8651. View